REFERENCES
-
1
Ratziu V, Bonyhay L, Di Martino V et al..
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Hepatology.
2002;
35
1485-1493
-
2
Cavaghan M K, Ehrmann D A, Polonsky K S.
Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
J Clin Invest.
2000;
106
329-333
-
3
Reaven G M.
Pathophysiology of insulin resistance in human disease.
Physiol Rev.
1995;
75
473-486
-
4
Bugianesi E, Leone N, Vanni E et al..
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
Gastroenterology.
2002;
123
139-140
-
5
Nair S, Mason A, Eason J, Loss G, Perrillo R P.
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?.
Hepatology.
2002;
36
150-155
-
6
Bralet M P, Regimbeau J M, Pineau P et al..
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases.
Hepatology.
2000;
32
200-204
-
7
Bioulac-Sage P, Le Bail B L, Winnock M et al..
Occurrence of hepatocellular carcinoma in nonfibrotic livers.
Hepatology.
2000;
32
1411-1412
-
8
Shimada M, Hashimoto E, Taniai M et al..
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
J Hepatol.
2002;
37
154-160
-
9
Cotrim H P, Parana R, Braga E, Lyra R.
Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?.
Am J Gastroenterol.
2000;
95
3018-3019
-
10
Zen Y, Katayanagi K, Tsuneyama K et al..
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
Pathol Int.
2001;
51
127-131
-
11
Regimbeau J M, Colombat M, Mognol P et al..
Obesity and diabetes as a risk factor for hepatocellular carcinoma.
Liver Transpl.
2004;
10(suppl)
s69-73
-
12
Brunt E M.
Nonalcoholic steatohepatitis.
Semin Liver Dis.
2004;
24
3-20
-
13
Yang S, Lin H Z, Hwang J, Chacko V P, Diehl A M.
Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?.
Cancer Res.
2001;
61
5016-5023
-
14
Nemoto Y, Toda K, Ono M et al..
Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice.
J Clin Invest.
2000;
105
1819-1825
-
15
Reue K, Xu P, Wang X P, Slavin B G.
Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene.
J Lipid Res.
2000;
41
1067-1076
-
16
Yokogawa K, Yonekawa M, Tamai I et al..
Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice.
Hepatology.
1999;
30
997-1001
-
17
Soga M, Kishimoto Y, Kawamura Y et al..
Spontaneous development of hepatocellular carcinomas in FLS mice with hereditary fatty liver.
Cancer Lett.
2003;
196
43-48
-
18
Fan C Y, Pan J, Usuda N, Yeldandi A V, Rao M S, Reddy J K.
Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.
J Biol Chem.
1998;
273
15639-15645
Dr.
Paulette Bioulac-Sage
GREF Inserm 0362 Université Bordeaux 2
Bordeaux, France
eMail: paulette.bioulac-sage@gref.u-bordeaux2.fr
